Whatever run it takes it'll be steady and smooth. Investors don't want out. Tightly held and on the back of more annoucements, who would want out.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025